PolyPeptide Group Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Juan Gonzalez
Chief executive officer
€2.7m
Total compensation
| CEO salary percentage | 31.1% |
| CEO tenure | 2yrs |
| CEO ownership | 0.7% |
| Management average tenure | 2.3yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
PolyPeptide Group AG (VTX:PPGN) Might Not Be As Mispriced As It Looks After Plunging 28%
Apr 08
Why PolyPeptide Group AG (VTX:PPGN) Could Be Worth Watching
Feb 04Many Still Looking Away From PolyPeptide Group AG (VTX:PPGN)
Jan 09PolyPeptide Group AG's (VTX:PPGN) Intrinsic Value Is Potentially 19% Below Its Share Price
Nov 11PolyPeptide Group (VTX:PPGN) Is Making Moderate Use Of Debt
Oct 21Sentiment Still Eluding PolyPeptide Group AG (VTX:PPGN)
Sep 16Does PolyPeptide Group (VTX:PPGN) Have A Healthy Balance Sheet?
Jun 19Further Upside For PolyPeptide Group AG (VTX:PPGN) Shares Could Introduce Price Risks After 33% Bounce
Mar 14PolyPeptide Group AG's (VTX:PPGN) Intrinsic Value Is Potentially 99% Above Its Share Price
Mar 13PolyPeptide Group AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 18Investors Shouldn't Be Too Comfortable With PolyPeptide Group's (VTX:PPGN) Robust Earnings
Mar 23CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2024 | €3m | €842k | -€20m |
| Sep 30 2024 | n/a | n/a | -€24m |
| Jun 30 2024 | n/a | n/a | -€29m |
| Mar 31 2024 | n/a | n/a | -€40m |
| Dec 31 2023 | €2m | €604k | -€51m |
Compensation vs Market: Juan's total compensation ($USD3.08M) is above average for companies of similar size in the Swiss market ($USD1.31M).
Compensation vs Earnings: Juan's compensation has increased whilst the company is unprofitable.
CEO
Juan Gonzalez (52 yo)
2yrs
Tenure
€2,707,411
Compensation
Mr. Juan Jose Gonzalez serves as CEO at PolyPeptide Group AG since April 12, 2023. He had been Chief Executive Officer of Ambu A/S since May 15, 2019 until May 20, 2022 and supports the new CEO (Britt Meel...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 2yrs | €2.71m | 0.69% CHF 3.9m | |
| Chief Financial Officer | 1.3yrs | no data | 0.0076% CHF 43.3k | |
| Director of Global Operations | 2.3yrs | no data | 0.0042% CHF 23.9k | |
| Director of Corporate Finance | no data | no data | no data | |
| Director of Global Innovation & Technology | no data | no data | no data | |
| Head of Investor Relations & Corporate Communications | no data | no data | no data | |
| Chief Legal Officer & Corporate Secretary | 3.6yrs | no data | no data | |
| Corporate Compliance Manager | no data | no data | no data | |
| Interim Director Global Sales & Marketing | no data | no data | no data | |
| Chief Human Resources Officer | 2.9yrs | no data | no data | |
| Head of Technical Department - Braine | no data | no data | no data | |
| Chief Information Security Officer & Global IT Services VC | no data | no data | no data |
2.3yrs
Average Tenure
52yo
Average Age
Experienced Management: PPGN's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Vice Chairman & Lead Independent Non-Executive Director | 4.3yrs | €238.63k | 0.061% CHF 346.1k | |
| Non-Executive Chair of the Board of Directors | 4.3yrs | €358.55k | 0.093% CHF 530.9k | |
| Independent Non-Executive Director | 4.3yrs | €224.89k | 0.067% CHF 381.8k | |
| Non-Executive & Independent Director | 4.3yrs | €148.98k | 0.078% CHF 447.8k | |
| Non-Executive Director | 4.3yrs | no data | 0.0097% CHF 55.3k | |
| Independent Director | no data | no data | no data |
4.3yrs
Average Tenure
67yo
Average Age
Experienced Board: PPGN's board of directors are considered experienced (4.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/25 00:19 |
| End of Day Share Price | 2025/04/25 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
PolyPeptide Group AG is covered by 17 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Konstantin Wiechert | Baader Helvea Equity Research |
| Volker Bosse | Baader Helvea Equity Research |
| Thomas Meyer | Baader Helvea Equity Research |